Self-assembling percutaneously implantable heart valve

US2016193045A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016193045-A1
Application numberUS-201414912450-A
CountryUS
Kind codeA1
Filing dateAug 26, 2014
Priority dateAug 29, 2013
Publication dateJul 7, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Devices and methods for the treatment of heart conditions. For example, a prosthetic heart valve and a transcatheter heart valve replacement method. The prosthetic heart valve can be configured into a low-profile configuration for containment within a small diameter delivery sheath.

First claim

Opening claim text (preview).

1 . A prosthetic aortic valve device comprising: a stent portion comprising a plurality of elongate members that form an open cylinder defining an interior space and having a distal end and a proximal end, wherein the stent portion is configurable between a collapsed configuration and an expanded configuration, and wherein the stent portion is configured to self-expand from the collapsed configuration to the expanded configuration when the stent portion is cause to emerge from containment within a delivery sheath; and a plurality of leaflets comprising a flexible material, the leaflets having a partially disassembled delivery configuration and an assembled configuration, wherein in the partially disassembled delivery configuration the leaflets are at least partially located outside of the interior space. 2 . The prosthetic aortic valve device of claim 1 , wherein in the assembled configuration the leaflets are joined together in a generally cylindrical shape, and wherein the leaflets are located within the interior space when the stent portion is in the expanded configuration. 3 . The prosthetic aortic valve device of claim 1 , wherein the leaflets are attached to each other at struts that are attached to the stent portion when the leaflets are in the assembled configuration and the stent portion is in the expanded configuration. 4 . The prosthetic aortic valve device of claim 1 , wherein the leaflets include one or more reinforcing members located along one edge of the leaflets, and wherein each of the one or more reinforcing members is attached to the stent portion when the leaflets are in the assembled configuration and the stent portion is in the expanded configuration. 5 . The prosthetic aortic valve device of claim 4 , wherein the one or more reinforcing members comprises three reinforcing members. 6 . The prosthetic aortic valve device of claim 1 , further comprising a plurality of attachment features fixed to the plurality of leaflets, wherein the plurality of attachment features are selectively attachable to the stent portion. 7 . The prosthetic aortic valve device of claim 1 , further comprising a plurality of attachment features fixed to the stent portion, wherein the plurality of attachment features are selectively attachable to the plurality of leaflets. 8 . A TAVR system comprising: an elongate delivery sheath having an interior lumen; a catheter that is disposable within the lumen; a prosthetic aortic valve device comprising: a stent portion that is configurable between a collapsed configuration for containment within the lumen and an expanded configuration, and wherein the stent portion is configured to self-expand from the collapsed configuration to the expanded configuration when the stent portion is cause to emerge from containment within the delivery sheath; and a plurality of leaflets comprising a flexible material, the leaflets having a partially disassembled delivery configuration in which the leaflets are spiraled around the catheter and an assembled configuration, wherein in the partially disassembled delivery reconfiguration the leaflets are at least partially located outside of the interior space; and a balloon that has an inflated configuration, and wherein the balloon has a deflated configuration in which the balloon can be contained within the lumen. 9 . The TAVR system of claim 8 , wherein in the assembled configuration the leaflets are joined together in a generally cylindrical shape, and wherein the leaflets are located within an interior space defined by the stent portion when the stent portion is in the expanded configuration. 10 . The TAVR system of claim 8 , wherein the leaflets are attached to each other at struts that are attached to the stent portion when the leaflets are in the assembled configuration and the stent portion is in the expanded configuration. 11 . The TAVR system of any of claim 8 , wherein the leaflets include one or more reinforcing members located along one edge of the leaflets, and wherein each of the one or more reinforcing members is attached to stent portion when the leaflets are in the assembled configuration and the stent portion is in the expanded configuration. 12 . The TAVR system of claim 11 , wherein the one or more reinforcing members comprises three reinforcing members. 13 . The TAVR system of any of claim 8 , further comprising a plurality of attachment features fixed to the plurality of leaflets, wherein the plurality of attachment features are selectively attachable to the stent portion. 14 . The TAVR system of any of claim 8 , further comprising a plurality of attachment features fixed to the stent portion, wherein the plurality of attachment features are selectively attachable to the plurality of leaflets. 15 . A TAVR method comprising: installing within a lumen of a delivery sheath: a catheter; a prosthetic aortic valve device comprising: a stent portion that is configurable between a collapsed configuration for containment within the lumen and an expanded configuration, and wherein the stent portion is configured to self-expand from the collapsed configuration to the expanded configuration when the stent portion is cause to emerge from containment within the delivery sheath; and a plurality of leaflets comprising a flexible material, the leaflets having a partially disassembled delivery configuration in which the leaflets are closely contained around the catheter and an assembled configuration, wherein in the partially disassembled delivery configuration the leaflets are at least partially located outside of the interior space; and a balloon that has an inflated configuration and a deflated configuration in which the balloon can be contained within the lumen; percutaneously inserting the delivery sheath within a patient's vasculature and navigating a distal tip of the delivery sheath to a location near the patient's aortic valve; causing the stent portion to emerge from the distal tip of the delivery sheath such that the stent portion self-expands to the expanded configuration within the patient's aortic valve; causing the leaflets to reconfigure from the disassembled delivery configuration to the assembled configuration; and inflating the balloon to force the leaflets to attach to the stent portion. 16 . The TAVR method of claim 15 , further comprising a plurality of attachment features fixed to the plurality of leaflets, wherein the inflating the balloon to force the leaflets to attach to the stent portion comprises attachment of at least some of the plurality of attachment features to the stent portion. 17 . The TAVR method of claim 15 , further comprising a plurality of attachment features fixed to the stent portion, wherein the inflating the balloon to force the leaflets to attach to the stent portion comprises attachment of at least some of the plurality of attachment features to the plurality of leaflets. 18 . The TAVR method of claim 15 , wherein the leaflets in the partially disassembled delivery configuration are wrapped around the catheter. 19 . The TAVR method of claim 15 , wherein the leaflets in the partially disassembled delivery configuration are spirally-wrapped around the catheter.

Assignees

Inventors

Classifications

  • Annuloplasty rings in direct contact with the valve annulus · CPC title

  • A61F2/2427Primary

    Devices for manipulating or deploying heart valves during implantation · CPC title

  • Support rings therefor, e.g. for connecting valves to tissue (annuloplasty rings A61F2/2442) · CPC title

  • cylindrical · CPC title

  • with pivoting rigid closure members (check valves with hinged closure members in general F16K15/03) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016193045A1 cover?
Devices and methods for the treatment of heart conditions. For example, a prosthetic heart valve and a transcatheter heart valve replacement method. The prosthetic heart valve can be configured into a low-profile configuration for containment within a small diameter delivery sheath.
Who is the assignee on this patent?
Mayo Foundation
What technology area does this patent fall under?
Primary CPC classification A61F2/2427. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jul 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).